Sale!

ACTN2 Gene Cardiomyopathy Dilated Type 1AA Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ACTN2 gene plays a critical role in the structure and function of heart muscle cells, and mutations in this gene are associated with dilated cardiomyopathy type 1AA, a condition characterized by the enlargement and weakening of the heart’s main pumping chamber. The ACTN2 Gene Cardiomyopathy Dilated Type 1AA Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the ACTN2 gene that may predispose individuals to this specific type of heart disease.

By analyzing a sample of the patient’s DNA, this test can identify the presence of genetic variations that are linked to dilated cardiomyopathy type 1AA, providing crucial information for early diagnosis, management, and treatment planning. The test is priced at 4400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, where advanced genetic testing technologies ensure accurate and reliable results. This test is particularly recommended for individuals with a family history of cardiomyopathy or unexplained heart failure, as it can help in taking preemptive health measures and informing family planning decisions.

Description

ACTN2 Gene Cardiomyopathy Dilated Type 1AA Genetic Test

Test Name: ACTN2 Gene Cardiomyopathy Dilated Type 1AA Genetic Test

Components: NGS Technology

Price: 4400.0 AED

Sample Condition: Blood

Report Delivery: 3 to 4 Weeks

Test Type: Cardiovascular Pneumology Disorders

Doctor: Cardiologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for ACTN2 Gene Cardiomyopathy, dilated type 1AA NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ACTN2 Gene Cardiomyopathy, dilated type 1AA NGS Genetic DNA Test gene ACTN2

Test Details: ACTN2 gene cardiomyopathy, dilated type 1AA is a type of genetic test that uses next-generation sequencing (NGS) technology to analyze the ACTN2 gene for mutations. Cardiomyopathy refers to a group of diseases that affect the heart muscle, leading to abnormal heart function. Dilated cardiomyopathy is a specific type characterized by enlargement and weakened pumping ability of the heart chambers. The ACTN2 gene provides instructions for producing the alpha-actinin-2 protein, which plays a crucial role in maintaining the structure and function of heart muscle cells. Mutations in the ACTN2 gene can disrupt the normal functioning of alpha-actinin-2, leading to the development of dilated cardiomyopathy. NGS genetic testing involves sequencing the DNA of an individual to identify specific genetic variations or mutations associated with a particular condition. In the case of ACTN2 gene cardiomyopathy, dilated type 1AA, NGS genetic testing aims to detect mutations in the ACTN2 gene that may contribute to the development of dilated cardiomyopathy. By identifying these mutations, healthcare professionals can provide individuals with a more accurate diagnosis, assess the risk of developing cardiomyopathy, and offer personalized treatment options or genetic counseling for affected individuals and their families.

Test Name	ACTN2 Gene Cardiomyopathy dilated type 1AA Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Cardiovascular Pneumology Disorders
Doctor	Cardiologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for ACTN2 Gene Cardiomyopathy, dilated type 1AA NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ACTN2 Gene Cardiomyopathy, dilated type 1AA NGS Genetic DNA Test gene ACTN2
Test Details	ACTN2 gene cardiomyopathy, dilated type 1AA is a type of genetic test that uses next-generation sequencing (NGS) technology to analyze the ACTN2 gene for mutations. Cardiomyopathy refers to a group of diseases that affect the heart muscle, leading to abnormal heart function. Dilated cardiomyopathy is a specific type characterized by enlargement and weakened pumping ability of the heart chambers. The ACTN2 gene provides instructions for producing the alpha-actinin-2 protein, which plays a crucial role in maintaining the structure and function of heart muscle cells. Mutations in the ACTN2 gene can disrupt the normal functioning of alpha-actinin-2, leading to the development of dilated cardiomyopathy. NGS genetic testing involves sequencing the DNA of an individual to identify specific genetic variations or mutations associated with a particular condition. In the case of ACTN2 gene cardiomyopathy, dilated type 1AA, NGS genetic testing aims to detect mutations in the ACTN2 gene that may contribute to the development of dilated cardiomyopathy. By identifying these mutations, healthcare professionals can provide individuals with a more accurate diagnosis, assess the risk of developing cardiomyopathy, and offer personalized treatment options or genetic counseling for affected individuals and their families.